Medicine and Dentistry
Acromegaly
14%
Adult
18%
Age
35%
Amaurosis
7%
Analysis
9%
Antidiabetic Agent
6%
Antithyroid Agent
9%
Assessment
12%
Association
48%
Autonomic Neuropathy
7%
Bisphosphonate
6%
Bone
18%
Bone Density
28%
Bone Turnover
15%
Brain
9%
Cardiovascular Disease
7%
Cardiovascular System
12%
Chemotherapeutic Agent
8%
Child
20%
Childbirth
13%
Clinical Trial
6%
Cohort Analysis
42%
Cohort Effect
7%
Combination Therapy
15%
Cross Sectional Study
6%
Development
14%
Diabetes
71%
Diabetes Mellitus
26%
Diabetic Neuropathy
16%
Diagnosis
26%
Diseases
13%
Drug
8%
First Trimester Pregnancy
13%
Follow up
18%
Fracture
46%
Fragility Fracture
7%
Gender
7%
Glucose
29%
Glycon
11%
Graves' Disease
10%
Growth Hormone
7%
Hazard Ratio
11%
Health
7%
Hip
6%
Hip Fracture
6%
Hospital
6%
Hyperthyroidism
7%
Hypoglycemia
15%
Hypothyroidism
14%
Incidence
31%
Inpatient
63%
Insulin
20%
Insulin Dependent Diabetes Mellitus
52%
Iodine
17%
Iodine Deficiency
9%
Learning
7%
Liraglutide
7%
Malignant Neoplasm
6%
Man
10%
Maturity Onset Diabetes of the Young
49%
Measurement
8%
Meta-Analysis
17%
Metabolite
6%
Monitoring
7%
Mortality
19%
Neuropathy
11%
Odds Ratio
6%
Osteoporosis
14%
Pain
6%
Parathyroid Hormone
8%
Patient
100%
Patient with Diabetes
10%
Patient with Type 1 Diabetes
9%
Patient with Type 2 Diabetes
17%
Peripheral Neuropathy
9%
Person
9%
Placebo
14%
Polyneuropathy
13%
Predictor
13%
Pregnancy
28%
Prevalence
22%
Primary Hyperparathyroidism
15%
Quality of Life
8%
Retrospective Cohort Study
7%
Screening
6%
Serum
14%
Smoking
6%
Spontaneous Remission
6%
Supplementation
8%
Surgery
7%
Symptom
10%
Systematic Review
14%
Telemedicine
8%
Therapeutic Procedure
53%
Thyroid Disease
16%
Thyroid Function
9%
Thyroid Gland
14%
Thyroid Hormone
6%
Thyroid Medullary Carcinoma
9%
Woman
21%
Pharmacology, Toxicology and Pharmaceutical Science
Acromegaly
5%
Alendronic Acid
9%
Antidiabetic Agent
7%
Antithyroid Agent
23%
Bisphosphonic Acid Derivative
15%
Blindness
5%
Calcium
7%
Case-Control Study
11%
Cohort Study
32%
Comorbidity
7%
Congenital Malformation
15%
Denosumab
9%
Diabetes Mellitus
25%
Dipeptidyl Peptidase IV Inhibitor
5%
Diseases
9%
Drug
17%
Epidemiology
5%
Fracture
56%
Fragility Fracture
13%
Glucagon Like Peptide 1 Receptor Agonist
6%
Glucocorticoid
7%
Glucose
7%
Graves Disease
17%
Growth Hormone
5%
Hip Fracture
8%
Hyperthyroidism
16%
Hypoglycemia
11%
Hypothyroidism
10%
Incidence
28%
Insulin
18%
Insulin Analog
7%
Insulin Degludec
5%
Insulin Dependent Diabetes Mellitus
9%
Insulin Glargine
5%
Iodine
15%
Malignant Neoplasm
5%
Metformin
11%
Mineral
9%
Mortality
7%
Non Insulin Dependent Diabetes Mellitus
24%
Osteoporosis
20%
Parathyroid Hormone
7%
Phosphate
5%
Placebo
15%
Prevalence
11%
Primary Hyperparathyroidism
6%
Propylthiouracil
8%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Survival
8%
Thyroid Disease
13%
Thyroid Hormone
11%
Thyroid Medullary Carcinoma
6%
Thyrotoxicosis
6%
Thyrotropin
9%
Vitamin D
10%
Nursing and Health Professions
Adult
8%
Antidiabetic Agent
6%
Bone Density
5%
Case-Control Study
5%
Cohort Analysis
12%
Comorbidity
5%
Confidence Interval
7%
Control
11%
Diabetes Mellitus
38%
Diagnosis
15%
Diseases
5%
Dose
6%
Drug
5%
Drug Therapy
5%
Evaluation Study
5%
Follow up
9%
Fracture
31%
Fragility Fracture
9%
Glucose
9%
Hazard Ratio
6%
Hyperthyroidism
11%
Hypoglycemia
12%
Hypothyroidism
27%
Incidence
21%
Inpatient
10%
Insulin
10%
Insulin Dependent Diabetes Mellitus
18%
Iodine Deficiency
5%
Man
7%
Measurement
6%
Meta Analysis
13%
Mortality
17%
Nocturnal Hypoglycemia
5%
Non Insulin Dependent Diabetes Mellitus
21%
Osteoporosis
9%
Patient
45%
Patient with Diabetes
5%
Placebo
8%
Prediction
6%
Prevalence
6%
Prevention
6%
Primary Hyperparathyroidism
10%
Procedures
7%
Quality of Life
5%
Rate Ratio
5%
Symptom
8%
Systematic Review
17%
Telemedicine
6%
Thyroid Disease
11%
Time
16%
Tincture of Iodine
18%
Urine Sampling
5%
Woman
20%